Sanofi Top UK Exec Plans For Hard Brexit, Blasts 'Poor Access' To New Drugs

The managing director for Sanofi in the UK says clinical trials there will become less likely in future if access to innovative drugs doesn't improve, causing comparative standards of care to deteriorate.